However, in glioblastoma, the specific gene product induced by DNER-mediated histone deacetylase (HDAC) inhibition inhibits the growth of GBM-derived neurospheres, induces differentiation in vitro and in vivo and inhibits tumour xenograft growth14. The gene discussed is HDAC9; the disease is glioblastoma.